LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cellsBaoguo Li, Weihao Zhang, Changfu Liu et al.|Life Sciences|2018Cited by 209
Donafenib and sintilimab combined with hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma: a prospective, single-arm phase II trial (DoHAICs study)Wei Gao, Zhao-Long Pan, Wei‐Yang Lu et al.|EClinicalMedicine|2025Cited by 9